Delivery Order SPE2DB20D2014-SPE2DB24FA93Q
Award Date
1/29/24
Potential Completion Date
1/30/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,362.77 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. This delivery order contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this contract, which is not designated as a set-aside. The award is associated with a larger indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency, with a ceiling value of $1,248.70. The contract has a firm fixed-price pricing type and an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML to the Defense Logistics Agency (DLA). The $1,312.65 firm fixed-price delivery order has a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract has a potential value of $1,575.18 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,440.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a completion date of April 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD)...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $3,937.95 to provide XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen Drug Corp to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,480.22 firm fixed-price delivery order is for the XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $1,746.17 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The award has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and does not have a set-aside designation for this award. In addition to this specific delivery order,...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,072.07, is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of the prescription drug XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract, valued at $1,050.12, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a logistics combat support agency of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA...